This milestone reflects confidence in iRhythm’s solutions, contributing to the stock's favorable price performance following the news. The FDA clearance underscores iRhythm’s commitment to ...

Once the lockup period is over, the Republican presidential candidate has the all-clear to start selling his stock. If he chooses to do so, it could be a major headwind for investors, given that ...